endothelin-1 ET-1
Selected indexed studies
- Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions. (Clin Sci (Lond), 2024) [PMID:39106080]
- Aprocitentan, a dual endothelin-1 (ET-1) antagonist for treating resistant hypertension: Mechanism of action and therapeutic potential. (Drug Discov Today, 2023) [PMID:37742911]
- Air Pollution-Induced Vascular Dysfunction: Potential Role of Endothelin-1 (ET-1) System. (Cardiovasc Toxicol, 2016) [PMID:26148452]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions. (2024) pubmed
- Aprocitentan, a dual endothelin-1 (ET-1) antagonist for treating resistant hypertension: Mechanism of action and therapeutic potential. (2023) pubmed
- Air Pollution-Induced Vascular Dysfunction: Potential Role of Endothelin-1 (ET-1) System. (2016) pubmed
- Endothelin-1 in Health and Disease. (2023) pubmed
- The human heart endothelin system: ET-1 synthesis, storage, release and effect. (2000) pubmed
- Endothelin-1 (ET-1) and vein graft failure and the therapeutic potential of ET-1 receptor antagonists. (2011) pubmed
- Endothelin-1 and human platelets. (2005) pubmed
- Nociceptive sensitization by endothelin-1. (2009) pubmed
- Endothelin-1 in the pathophysiology of obesity and insulin resistance. (2020) pubmed
- Combination of Endothelin-1 (ET-1) and L-NAME to Induce Murine Focal Cortical Stroke with Persistent Sensorimotor Deficits. (2022) pubmed